內(nèi)科試題呼吸練習(xí)題無答案_第1頁
內(nèi)科試題呼吸練習(xí)題無答案_第2頁
內(nèi)科試題呼吸練習(xí)題無答案_第3頁
內(nèi)科試題呼吸練習(xí)題無答案_第4頁
內(nèi)科試題呼吸練習(xí)題無答案_第5頁
已閱讀5頁,還剩30頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、 A1XB.D.D.B.最具特征的XB.是 A1XB.D.D.B.最具特征的XB.是B.57A.35D.911 C.79A.D.C.E. D. 18 A.D.C.E. D. 18 E.瘤E.A2題 男WBC11.1109/L,最可能的 是D.10,X,WBC22109/L,91%,下列治B.A.CTD.10,X,WBC22109/L,91%,下列治B.A.CTD.是是吸9. 20時(shí)加劇,輕咳,痰少。體檢:T39,P120,R30A.E.XD.200C.D.E.是C.A3題D.200C.D.E.是C.A3題D.A.2B.B.3C.4D.6E.8是B.A1題E.A.A.D.XB.A1題E.A.A.

2、D.X)是B.C.E.B.B.的B.C.E.B.B.的A.C.B.A.E.C.胸液A2DE.C.胸液A2D(+異煙肼加利福平加吡嗪酰胺24A.C.是8.女,23歲,患右上肺結(jié)核并空洞,曾用過 INHO.3g天,RFPO.4g天, D.,100ml,查體未見異常。ECG、AVFST0.5mV,T劑是8.女,23歲,患右上肺結(jié)核并空洞,曾用過 INHO.3g天,RFPO.4g天, D.,100ml,查體未見異常。ECG、AVFST0.5mV,T劑B.是D.CTB.D.500來A.15患者,1633839,伴咳嗽,表情淡漠,全身無皮疹、出A.B.17A.D.CT15患者,1633839,伴咳嗽,表情

3、淡漠,全身無皮疹、出A.B.17A.D.CT性,2A3。男,30XE.C.B.A.INHSMPAS,12E.C.B.A.INHSMPAS,12A1B.D.C.E.E.是A.B.E.是A.B.C.C.9.胸部XFEV1FVC70 化為E.B.染D.E.A.B.C.D.E.B.E.C.18E.8A2型D.E.A.B.C.D.E.B.E.C.18E.8A2型、B.AD是BC是FEV1/FVC65%45%,觀察采A5.64干咳無痰,肺功能檢查: FEV1%pre:45.6ABDA3題(13題共用題干E,70歲,慢性咳嗽、咳痰14年,多為白粘痰,每年發(fā)作3個(gè)月左右,近半DA3題(13題共用題干E,70歲

4、,慢性咳嗽、咳痰14年,多為白粘痰,每年發(fā)作3個(gè)月左右,近半分葉72,淋巴26,嗜酸2,尿常規(guī)正常。B.E.D.A.XA1A.B.D.B.痰A(chǔ). E.能為2痰A(chǔ). E.能為2受體激動(dòng)劑所抑制(AHRB.補(bǔ)液氨茶堿2 A2女性,32XD.CT緩解后再拍攝XRV、TLC A.XC.CT A.胸部X 530 歲男,自幼出現(xiàn)發(fā)作性呼吸 A.XC.CT A.胸部X 530 歲男,自幼出現(xiàn)發(fā)作性呼吸 ,60 C.X730 3 A. , 932 歲自幼患發(fā)作性呼吸發(fā)作時(shí)經(jīng)用藥數(shù)小時(shí)至數(shù)日緩解。,A3題D.化E.C.可選D.化E.C.可選7血?dú)夥治鰹椋篜aO250mmHg,PaCO2 )。C.XA.PaCO2

5、血?dú)夥治鰹椋篜aO250mmHg,PaCO2 )。C.XA.PaCO2C.A1題化E.呼 A1題藥 呼 A1題藥 E.B.4Lmin 5 呼吸衰竭患者血?dú)夥治鼋Y(jié)果pH7.188 PaCO275mmHgHCO3-27.6mmolL,BE-5mmolL,據(jù)此8 A2題 E. C.PaO2、PaCO2正常、pH E.PaOA2題 E. C.PaO2、PaCO2正常、pH E.PaO2 正常, PaCO2、pHB.PaO2正常、PaCO2、pHD.PaO2、PaCO2、3男患,68 歲,20 年,加重,E.459歲,20年,10 天,昏睡一天,10次/分、表淺,肺聞干濕羅音,110次/分,Bp120/

6、85mmHg,pH7.293、PaO232mmHg、 E.,BE+12mmol/L,血鉀 3.2mmol/L、氯劑A.PHB.PHC.PHPaO250mmHg,PaCO280mmHg PaO250mmHg,PaCO250mmHg PaO280mmHg,D.PHE.PHPaO250mmHg, PaCO230mmHg PaO2125mmHg,PaCO220mmHg865 歲,肺心病患者,經(jīng)過治療興奮躁動(dòng),血?dú)夥治?PH7.48、PaO250mmHgPaCO275mmHg、BE+10mmol/L、HCO340mmol/L,血氯 E. D.PHE.PHPaO250mmHg, PaCO230mmHg P

7、aO2125mmHg,PaCO220mmHg865 歲,肺心病患者,經(jīng)過治療興奮躁動(dòng),血?dú)夥治?PH7.48、PaO250mmHgPaCO275mmHg、BE+10mmol/L、HCO340mmol/L,血氯 E. D.2,3DPG 水平降低10男、50歲,7年,2天、伴尿少、痰粘。體檢: 患者,72 20 - 30mmHg,PaCO2 60mmHg. 吸氧后神志不清,血?dú)夥治觯篜aO2 A3題(13題共用題干A.MRI 檢查E.E.3其血?dú)夥治鼋Y(jié)果是 H7.50,PaO270mmHg,PaCO260mmHg,HCO3- 為D. A4題(14 題共用備選) pH7.335PaO250Hga2

8、78mmHg,HCO3 -34mmolL.D. A4題(14 題共用備選) pH7.335PaO250Hga2 78mmHg,HCO3 -34mmolL. (58題共用題干 。E.片。血?dú)鈾z查:PaO2 4.0ka(FiO20A1A.是B.D.56A1A.是B.D.56B.A.C.B.B.E.心率120D.B.B.E.心率120D.C.PE.V1E.KerleyB是E.A2題1,45C.K、Na、Cl其A.E.化1,45C.K、Na、Cl其A.E.化是 A1C.CEA卵A 57B 45C 34D 79A2型E 9101男,40 1 是D 79A2型E 9101男,40 1 是E. A3 題型(

9、13題共用題干,70203423 年出有關(guān),繼之出現(xiàn)呼吸 、大汗,不能平臥,來院就診。 (45題共用題干男,2030ml 時(shí),患者突感頭暈心(68題共用題干 C.B(68題共用題干 C.BA11 對肺組織 劑B.2.A.B.C. A.5.E.pHC.B.PaCO27.A2B.C.A1題是化D.E.A2B.C.A1題是化D.E.2下列XA.證D.A.B.A.C.B.A.A.B.A.C.B.A.D.A2題1.50C.E.就診。常規(guī)XB.B.D.CTC.B.D.CTC.2張。纖支鏡檢查和活檢證實(shí)為小細(xì)胞未分化癌。CTB.A3E.A.3.E.D.E.B.腫D.腫3.E.D.E.B.腫D.腫1Which

10、ofthefollowingiscorrectregarding2Whichisnotcommonsymptomasso E)fevertedD)chesttightness3Whatagedoesasthmapresen A)any ageC)40yearsold E)60years4 Family history of asthma, regular smokeareof A)riskfactors ?D)10-12yearsg infections, and ure to 5Many of the symptoms of asthma are 100% _ with medication

11、 in some patients.6AirwayobstructionandairwaysensitivityareofHyper-reactivebronchiolesareMost children wisthmaarealsoatopic,meaningtheyproducelarge ties of IgA in response to environmental allergens.Thelateinflammatoryresponseinasthmaticairwayisthoughttobe he development of hyper-reactive airways.Pe

12、ak flow in asthma is usually besthemorningwithworseningduringthe Asthmaischaracterizedbypoorlyreversibleandprogressiveairflow E)riskD)7MrSundramhasnocturnalsymptomsaboutoncea guidelines his asthma is categorised as:k.AccordingtoermittentB)E)riskD)7MrSundramhasnocturnalsymptomsaboutoncea guidelines h

13、is asthma is categorised as:k.AccordingtoermittentB)Mild persistent asthma. D)Severepersistentasthma.C)Moderatepersistentasthma. E)None of the above.8Withregardtotheuseofinhaledcorticosteroidwhichofthefollowing ement is CORRECT:ItimprovesmorbidityandItsuseshouldbedoubledpriortoC)ItisermittentD)Itred

14、u E)Ittheriskofexacerbationsbutnottheriskofsevereexacerbationsonlyifgiveninhigh9Inapatientwithseverepersistentasthma,whichoneofthefollowingis A)ContinualdaytimeB)Nightsymptomsnorequalto5 timesaC)FEV1n65%D)PEFvariability20-30percent. E)None of the above.10Theasthmatherapyassessmentquestionnaireisbase

15、donwhichoneofthe A)Patientscontrolproblems C)PEF variability.E)None of the above. 11BronchodilatorcanNOTbeinhaledis A)short acting 2 receptor agonists12AsthmaisdifferentfromCOPDasA)IssodicB)OftenstartsinDoesnotprogressRespondswelltoinhaledcorticosteroidandshowsgoodreversibilityto Showsallofthe13Whic

16、hofthefollowingiscorrectregardingchronicobstructivepulmonary disease (COPD)?MostheavysmokersdeveloptheThemainsourceofairflowobstructionisthoughttobenarrowingofsmall ThetypicalspirometricfindingsareareducedFEV1 andap FEV1/FVC ratio.MostacuteexacerbationsofCOPDareduetoE) Hyper-reactive bronchioles are

17、 characteristic. 14Which of the following is the least likely feature of COPD:A)Isaslowlyprogressivecondition. B)Most patients are smokers.ShowslittlevariabilityinHaslimitedresponsetobronchodilatorsorcorticosteroids. E)Always distinguishable from asthma.15TheE) Hyper-reactive bronchioles are charact

18、eristic. 14Which of the following is the least likely feature of COPD:A)Isaslowlyprogressivecondition. B)Most patients are smokers.ShowslittlevariabilityinHaslimitedresponsetobronchodilatorsorcorticosteroids. E)Always distinguishable from asthma.15ThecharacteristicsofseverestageofCOPD16Thecommoneste

19、mphysemainclinicis A)obstructive emphysema C)compensatory emphysemaE)focusB)senile emphysema D) erstitialemphysemareatingCOPDA)2agonists 18Which of the following is not a pathophysiological feature of COPD: A)Developmentofemphysemacausinglossofdiffusingareaandimpairinggas B)Markedairwaysmoothmuscleh

20、ypertrophyandincreasedbronchial C)Closureofsmallairwaysleadingtoairtrap sensation of dyspnoea.,hyperinflationandD)LossgE)Inflammationofthesmallairwayswithinvolvementof19ThedesirableestobereatmentofincludeallofthefollowingEXCEPT: A)Reducing mortality.B)Preventing exacerbations. veofsymptomssaryE)Pres

21、ervingqualityof20Which of the following about antibiotic use in COPD is INCORRECT: A)AntibioticsisonlyindicatedinsevereacuteexacerbationsofCOPD withlypurulentB)Empirictreatmentwitheitherbetalactamormacrolideantibioticis C)EmpiricuseofquinoloneismendedunlessPTBcanbeD)Antibiotictreatmentbenefitsallpat

22、ientswi E)Empiric use of quinolone has been assocuteexacerbationsofCOPD. ted with delayed diagnosis of25Type II respiratory failure is 25Type II respiratory failure is C)PaO260mmHg,PaCO260mmHg E)PaO260mmHg,D)PaO260mmHg,PaCO226Which of the following is correct regarding diffuse parenchymaldiseases (D

23、PLDs)?Activation of macrophages leads to the laying down of fibrous tieand g scarring.gbiopsyisusuallyrequiredtoreachaDPLDsarecharacterizedbybronchialhyper-IdiopathicpulmonaryfibrosisrespondswelltosteroidPnemoconiosesnowaccountformost27WhichofthefollowingiscorrectgThemostcommonlyanismisHaemophilusIf

24、 an atypical ponia ispected,amacrolideantibioticsuchas erythromycin should be added to the treatment regime.AothoraxisacommonThe typical microscopic feature is the presence of neutrophilsRespiratory failure is a common complication . 22Whichofthefollowingiscorrectregardingtuberculosis?Thediseaseisca

25、usedbyMycoplasmaMostpeopleacquiringtheinfectiondevelopactivepulmonaryThemostcommonlyanismisHaemophilusMicroscopically,non-caseatinggranulomasareSymptoms of a chronic ponia is the typical presen23Whichofthefollowingiscorrectregardingrespiratoryfailure?Itisdefinedbya PaO2 nType1respiratoryfailureisusu

26、allyduetogeneralizedalveolar TreatmentshouldbeaimedattheunderlyingPatientswithchronicrespiratoryfailureeventuallydeveloppulmonary and right-sided heart failure.Itisdefinedbya PaCO2 n 24A healthy non-smoking 19-year-old man, hospitalised for an appendicectomy,ismistakenlygivenanoverdoseofhisnarcoticp

27、remedication. He is found unconscious and on ausculion of his chest, he has reduced breath sounds but no added sounds. Emergency chest X-ray is clear. His arterial blood gases (mHg), taken whireathing room air are MOST LIKELY to showA)pH -PaO2-PaCO2-B)pH -PaO2-PaCO2-C)pH-PaO2PaCO2-D)pH-PaO2-PaCO2-E)pH -PaO2-PaCO2-COPD(ChronicObstructivePulmonaryCOPDCOPDCOPD(ChronicObstructivePulmonaryCOPDCOPDX9 13? ItisthesecondmostcommoncancerSquamouscellcarcinomasaredefinedbyglandformationormucin production microscopically.AdenocarcinomastypicallyariseSma

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論